10 Best Dow Dividend Stocks For 2014

Alamy The company that set you up with that marked-down Thai restaurant meal last month and that half-priced spa treatment last week is now calling shotgun the next time you head to the grocery store. Groupon (GRPN) on Thursday introduced Snap, an app that provides cash rebates for buying promoted items. Shoppers simply download the free app, check current offers and then go shopping. They can go to any retailer. All they have to do is submit a picture of the receipt -- hence the "Snap" -- to get the predetermined rebate. They can cash out once they accumulate $20 in savings. Wall Street doesn't see Snap as a major disrupter. Coupons.com (COUP) and RetailMeNot (SALE) are two publicly traded companies that already specialize in Web-based bargains, and neither one opened sharply lower on Thursday's news. However, it would be unwise to underestimate Groupon. Hitting the Express Lane

Top 10 Semiconductor Stocks To Buy For 2015: General Mills Inc (GIS)

General Mills, Inc. (General Mills), incorporated on June 20, 1928, is a manufacturer and marketer of branded consumer foods sold through retail stores. The Company is also a supplier of branded and unbranded food products to the foodservice and commercial baking industries. The Company manufactures its products in 15 countries and markets them in more than 100 countries. The Company's joint ventures manufacture and market products in more than 130 countries and republics worldwide. General Mills operates in three segments: U.S. Retail, International, and Bakeries and Foodservice. In addition, the Company sells ready-to-eat cereals through its Cereal Partners Worldwide (CPW) joint venture. In February 2012, General Mills acquired Food Should Taste Good, a natural snack foods company based in Needham Heights, Mass. During the fiscal year ended May 27, 2012, the Company acquired a 51% interest in Yoplait S.A.S. and a 50% interest in Yoplait Marques S.A.S. In August 2012, it acquired Yoki Alimentos SA.

General Mills�� ready-to-eat cereals consists of Cheerios, Wheaties, Lucky Charms, Total, Trix, Golden Grahams, Chex, Kix, Fiber One, Reese�� Puffs, Cocoa Puffs, Cookie Crisp, Cinnamon Toast Crunch, Clusters, Oatmeal Crisp and Basic 4. Its refrigerated yogurt include Yoplait, Trix, Delights, Go-GURT, Fiber One, YoPlus, Whips!, Mountain High, Liberte, YOP, Perle de Lait, Petits Filous and Panier. The Company�� refrigerated and frozen dough products consists of Pillsbury, the Pillsbury Doughboy character, Grands!, Golden Layers, Big Deluxe, Toaster Strudel, Toaster Scrambles, Simply, Savorings, Jus-Rol, Latina, Pasta Master, Wanchai Ferry, V.Pearl and La Saltena. The dry dinners and shelf stable and frozen vegetable products includes Betty Crocker, Hamburger Helper, Tuna Helper, Chicken Helper, Old El Paso, Green Giant, Potato Buds, Suddenly Salad, Bac*O��, Betty Crocker Complete Meals, Valley Selections, Simply Steam, Valley Fresh Steamers, Wanchai Ferry, Diablitos and Parampara. Its gr! ain, fruit, and savory snacks consists of Nature Valley, Fiber One, Betty Crocker, Fruit Roll-Ups, Fruit By The Foot, Gushers, Chex Mix, Gardetto��, Bugles, Food Should Taste Good and Larabar. The sessert and baking mixes includes Betty Crocker, SuperMoist, Warm Delights, Bisquick and Gold Medal. Ready-to-serve soup consists of Progresso. The Company�� ice cream and frozen desserts include Haagen-Dazs, Secret Sensations, Cream Crisp and Dolce. Its frozen pizza and pizza snacks includes Totino��, Jeno��, Pizza Rolls, Party Pizza, Pillsbury Pizza Pops and Pillsbury Pizza Minis. General Mills�� organic products include Cascadian Farm and Muir Glen.

The Company�� products are marketed under trademarks and service marks that are owned by or licensed to the Company. Some of the brand names include Dora the Explorer, Disney Cars, and Disney Princesses for yogurt, and Dora the Explorer for cereal; Reese's Puffs for cereal; Hershey's chocolate for a variety of products; Weight Watchers as an endorsement for soup and frozen vegetable products; Macaroni Grill for dry and frozen dinners; Sunkist for baking products and fruit snacks; Cinnabon for refrigerated dough, frozen pastries, and baking products; Bailey's for super-premium ice cream, and a range of characters and brands for fruit snacks, including Scooby Doo, Batman, Tom and Jerry, Ocean Spray, Thomas the Tank Engine, My Little Pony, Transformers, and various Warner Bros. and Nickelodeon characters. Its primary customers include grocery stores, mass merchandisers, membership stores, natural food chains, drug, dollar and discount chains, commercial and noncommercial foodservice distributors and operators, restaurants, and convenience stores.

U.S. Retail segment

The Company�� U.S. Retail segment reflects business with a range of grocery stores, mass merchandisers, membership stores, natural food chains, and drug, dollar and discount chains operating throughout the United States. Its product categories in thi! s busines! s segment include ready-to-eat cereals, refrigerated yogurt, ready-to-serve soup, dry dinners, shelf stable and frozen vegetables, refrigerated and frozen dough products, dessert and baking mixes, frozen pizza and pizza snacks, grain, fruit and savory snacks, and a range of organic products, including granola bars, cereal and soup.

International segment

The Company�� International segment consists of retail and foodservice businesses outside of the United States. In Canada, its product categories include ready-to-eat cereals, shelf stable and frozen vegetables, dry dinners, refrigerated and frozen dough products, dessert and baking mixes, frozen pizza snacks, refrigerated yogurt, and grain and fruit snacks. In markets outside North America, its product categories include super-premium ice cream and frozen desserts, refrigerated yogurt, grain snacks, shelf stable and frozen vegetables, refrigerated and frozen dough products, and dry dinners. Its International segment also includes products manufactured in the United States for export, mainly to Caribbean and Latin American markets, as well as products it manufactures for sale to its international joint ventures.

Bakeries and Foodservice segment

In Company�� Bakeries and Foodservice segment its product categories include cereals, snacks, refrigerated yogurt, unbaked and fully baked frozen dough products, baking mixes, and flour. It sells to distributors and operators in many customer channels, including foodservice, convenience stores, vending and supermarket bakeries.

Advisors' Opinion:

• [By Dan Caplinger]

  McCormick has certainly been hitting it out of the park lately, with the stock rising to all-time highs in early April after the company announced positive earnings in its previous quarterly report. Between its solid balance sheet and its all-pervasive business model, McCormick has a stranglehold on its industry in a way that Fool analyst Jason Moser believes makes it a must-own for a long-term investor like Warren Buffett. Although the commercial side of the business, which supplies spices to companies like food giant General Mills (NYSE: GIS  ) and restaurant chain Yum! Brands (NYSE: YUM  ) , had relatively flat performance, the consumer side had strong growth.

• [By Joseph Solitro]

  General Mills (NYSE: GIS  ) General Mills is the parent company behind Betty Crocker, Pillsbury, Haagen-Dazs, Green Giant, Progresso, Yoplait, Cheerios and numerous other cereal and consumer product brands. It provides products to the U.S. and international retail segments, as well as to foodservice providers and convenience stores. Currently, General Mill's products are available in over 100 countries, with offices and manufacturing facilities in more than 30 of them.�

• [By Rich Duprey]

  Following its surprisingly controversial Cheerios commercial featuring a mixed-race family, cereal maker General Mills (NYSE: GIS  ) came out in support of Gay Pride Month using its Lucky Charms marshmallow rainbow as its rallying flag.

• [By Rich Smith]

  A few weeks back, I made the argument for why General Mills (NYSE: GIS  ) stock offers investors a pretty compelling bargain -- based on the stock's valuation, and relative to a couple of its larger rivals. Whether you value the stock on its GAAP earnings, its actual free cash flow ("cash profit"), or even on the size of its dividend yield, General Mills stock is cheaper, and pays you better, than do the stocks of either Kellogg (NYSE: K  ) or ConAgra Foods (NYSE: CAG  ) .

10 Best Dow Dividend Stocks For 2014: Arkema SA (AKE)

Arkema SA is a France-based company which specializes in the manufacture and marketing of chemical products. The Company operates through its two business segments: Industrial Chemicals and Performance Products. The Industrial Chemicals division offers the production of acrylics, polymethyl methacrylate (PMMA), hydrogen peroxide, fluorochemicals and thiochemicals, and includes such brands as Forane, Albone, Norsocryl, Altuglas and Sarbio. The Performance Products include the production of technical polymers, specialty chemicals and functional additives. The Company's products are used in the construction, automotive and transportation, health, electrical and electronics, agricultural and packaging industries, among others. In April 2013, it acquired a majority stake in AEC Polymers. In October 2013, it inaugurated the new Sumitomo Seika superabsorbent plant on the Carling site, which makes the overall superabsorbent production capacity of the Carling facility up to 47,000 ton/year. Advisors' Opinion:

• [By Inyoung Hwang]

  Arkema SA (AKE) added 4.7 percent to 83.93 euros. UBS AG raised its rating on the French chemicals maker to a buy from neutral, saying the stock is undervalued. The firm also boosted its price target to 100 euros from 80 euros.

10 Best Dow Dividend Stocks For 2014: United States Brent Oil Fund LP (BNO)

United States Brent Oil Fund, LP (USBO) is a commodity pool. USBO is focused on issuing units that may be purchased and sold on the NYSE Arca, Inc. The investment objective of USBO is for the daily changes in percentage terms of its units��per unit net asset value (NAV) to reflect the daily changes in percentage terms of the spot price of Brent crude oil, as measured by the daily changes in the price of the futures contract for Brent crude oil traded on the ICE Futures Exchange (the ICE Futures).

The investment portfolio of USBO will consist primarily of investments in futures contracts for crude oil, heating oil, gasoline, natural gas and other petroleum-based fuels that are traded on the ICE Futures, New York Mercantile Exchange (the NYMEX) or other United States and foreign exchanges (collectively, Futures Contracts). USBO may also take positions in other crude oil-related investments, such as cash-settled options on Futures Contracts, forward contracts for oil, cleared swap contracts and non-exchange traded (over-the-counter) transactions that are based on the price of crude oil, other petroleum-based fuels, Futures Contracts and indices based on the foregoing (collectively, Other Crude Oil-Related Investments).

Advisors' Opinion:

• [By Dr. Kent Moors]

  It's time to pull back a bit on exchange-traded fund (ETF) holdings allowing moves playing the WTI-Brent crude pricing spread. I have suggested previously the two primary plays here are PowerShares DB Energy (NYSE Arca: DBE) and United States Brent Oil Fund (NYSE Arca: BNO).

• [By David Fabian]

  Oil prices were once again in the spotlight for another round of heavy losses. The United States Brent Oil Fund, LP (NYSE: BNO) lost nearly 11 percent this week as this widely traded commodity fell to new 52-week lows. BNO tracks near-month Brent crude oil futures contracts traded on the ICE Futures Exchange.

10 Best Dow Dividend Stocks For 2014: BioTime Inc (BTX)

BioTime, Inc., incorporated on November 30, 1990, is a biotechnology company focused on the emerging field of regenerative medicine. Its commercial strategy is focused on its line of research products, such as ACTCellerate cell lines and associated ESpan culture media, HyStem hydrogels, human embryonic stem (hES) cell lines, and royalties from Hextend. Its focus is to provide regenerative therapies for age-related degenerative diseases. In January 2011, the Company acquired the assets of Cell Targeting, Inc. (CTI), a biotechnology company focused on methods of painting molecules on the surface of cells, which in turn causes the cells to adhere to particular tissues, such as those afflicted with disease. On March 21, 2011, the Company acquired Glycosan BioSystems, Inc. (Glycosan) through a merger of Glycosan with OrthoCyte Corporation (OrthoCyte). Through the merger, OrthoCyte acquired all of Glycosan�� assets, including Glycosan�� Hystem hydrogel product line. In March 2011, the Company entered into an agreement with XenneX, Inc., pursuant to which it organized LifeMap Sciences, Inc. (LifeMap), a subsidiary formed to advance the development and commercialization of its human embryonic stem (hES) cell data base. In August 2011, four hES cell lines (ESI-035, ESI-049, ESI-051 and ESI-053) developed by its subsidiary ES Cell International (ESI) were approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry. In May 2012, the Company acquired XenneX, Inc., through a merger of XenneX into LifeMap Sciences. In September 2012, the Company formed a wholly owned subsidiary, BioTime Acquisition Corporation. In October 2013, Geron Corporation announced the closing of the transaction to divest the Company's stem cell assets to Asterias Biotherapeutics, Inc., a subsidiary of BioTime, Inc.

HyStem is a biomaterial, which mimics the human extracellular matrix, which is the network of molecules surrounding cells in organs and tissues which is essent! ial to cellular function. Its HyStem hydrogels may have other applications when combined with the diverse and scalable cell types its scientists have isolated from hES cells. HyStem-Rx is a clinical grade formulation of HyStem-C, a biocompatible, implantable hyaluronan and collagen-based matrix for cell delivery in human clinical applications. Its subsidiary, OncoCyte Corporation, is developing PanC-Dx, a non-invasive blood-based cancer screening test designed to detect the presence of various human cancers, including cancers of the breast, lung, bladder, uterus, stomach, and colon, during routine check -ups. BioTime Asia, Limited (BioTime Asia) sells products for research use and may develop therapies to treat cancer and neurological and orthopedic diseases in Asia. OrthoCyte Corporation (OrthoCyte) is developing therapies to treat orthopedic disorders, diseases and injuries. ReCyte Therapeutics, Inc. (ReCyte Therapeutics) is developing therapies for age-related cardiovascular and blood disorders. Cell Cure Neurosciences Ltd. (Cell Cure Neurosciences), is a biotechnology company focused on developing stem cell-based therapies for retinal and other neurological disorders, including the development of retinal pigment epithelial (RPE) cells for the treatment of age-related macular degeneration. LifeMap Sciences, Inc. (LifeMap) is advancing the development and commercialization of our embryonic stem cell database and plans to make the database available for the marketing of research products and for use by stem cell researchers at pharmaceutical and biotechnology companies and other institutions via paid subscriptions or on a fee per use basis.

The Company�� blood plasma expander product, Hextend, is a physiologically balanced intravenous solution used in the treatment of hypovolemia, a condition caused by low blood volume, often from blood loss during surgery or injury. Hextend maintains circulatory system fluid volume and blood pressure, and keeps vital organs perfused during surgery and t! rauma car! e. Hextend is manufactured and distributed in the United States by Hospira, Inc., and in South Korea by CJ CheilJedang (CJ), under license from it.

Human Embryonic Stem Cell Lines for Research Use

Combined with the Company�� ACTCellerate technology, it derives of a range of markets human embryonic progenitor cells (hEPCs). ESI�� six current good manufacturing practices (cGMP) hES cell lines have been approved by the NIH for inclusion in the Human Embryonic Stem Cell Registry, which renders those cell lines eligible for use in federally funded research. The ESI hES cell lines are available for purchase through www.biotimeinc.com. It also markets hEPCs developed using ACTCellerate technology. Its hEPCs are also available for sale through www.biotimeinc.com. It derived the complete genome sequence of five of the ESI hES cell lines to facilitate the development of products derived from these cell lines. It has made these GMP-grade cell lines, along with certain documentation and complete genomic deoxyribonucleic acid (DNA) sequence information, available for sale.

The Company offers human stem cell products and technology that can be used by researchers at universities and at companies in the bioscience and biopharmaceutical industries. It has developed research and clinical grade hES cell lines, which it markets for both basic research and therapeutic product development. It also markets human embryonic progenitor cell (hEPCs) developed using ACTCellerate technology. These hEPCs are purified lineages of cells, which are intermediate in the developmental process between embryonic stem cells and fully differentiated cells. The ACTCellerate cell lines are also available for purchase through http://www.biotimeinc.com.

Human Embryonic Progenitor Cells

Through the Company�� subsidiary ReCyte Therapeutics, it had a license from Advanced Cell Technology, Inc. (ACT) to use ACTCellerate technology, and the rights to market more than 200 human c! ell types! made using that process. ACTCellerate allows the rapid isolation of hEPCs, which are cells that are intermediate in the developmental process between embryonic stem cells and fully differentiated cells.

Through an agreement with ReCyte Therapeutics, Millipore Corporation became a global distributor of ACTCellerate hEPC lines. In addition to the products, which it is co-marketing with Millipore, it offers 92 other ACTCellerate hEPC lines for purchase at www.biotimeinc.com. Through its subsidiary LifeMap, it provides online biomedical database services to increase awareness of molecular markers and diverse cell types comprising its ACTCellerate hEPC lines. It also focuses to market additional cell types manufactured with its PureStem technology. PureStem cell lines are produced by the exogenous expression of specific transcription factors, which regulate the differentiation of cell types from hES or induced pluripotent stem (iPS) cells. BioTime Asia has an agreement with Shanghai Genext Medical Technology Co., Ltd. to sell ACTCellerate hEPC lines and related ESpan growth media to the medical and biological research communities in China, Taiwan, Hong Kong, and Macau on an exclusive basis. The marketing agreement includes provisions for an initial stocking inventory and annual milestones to maintain exclusivity. The Company�� California Institute of Regenerative Medicine (CIRM)-funded research addresses the need for industrial scale production of purified therapeutic cells.

hES Cells Carrying Genetic Diseases

The Company focuses to add to its product line muscle progenitor cells produced from five hES cell lines carrying genes for Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, spinal muscular atrophy Type I, facioscapulohumeral muscular dystrophy 1A, and Becker muscular dystrophy. It obtained the diseased hES cell lines from Reproductive Genetics Institute (RGI).

ESpan Cell Growth Media

The Company is marketing a range of! cell-gro! wth media products called ESpan. These growth media are optimized for the growth of hEPC types. Cells need to be propagated in liquid media, in both the laboratory setting, where basic research on stem cells is performed, and in the commercial sector. Its ESpan products are marketed through Millipore and Genext.

ESpy Cell Lines

The Company focuses for development of ESpy cell lines. The ability of the ESpy cells to emit light will allow researchers to track the location and distribution of the cells in both in vitro and in vivo studies.

HyStem Hydrogel for Research and HyStem-Rx for Cell Delivery Medical Devices

HyStem is a patented biomaterial that mimics the ECM, the network of molecules surrounding cells in organs and tissues that is essential to cellular function. Its HyStem technology forms the foundation for stem cell delivery products in both the adult and embryonic stem cell marketplace, including products manufactured using its ACTCellerate technology. As an injectable product, HyStem-Rx may address need in cosmetic and reconstructive surgeries and other procedures by transplanting adipose derived cells or other adult stem cells. The transfer of cells in HyStem-Rx localizes the transplanted cells at the intended site and by providing a three-dimensional scaffold upon which cells can rebuild normal tissue. HyStem-Rx may support other emerging cell and tissue transplant therapies, such as those derived from hES and iPS cells, in addition to its potential application in the treatment of a range of conditions such as osteoarthritis, brain tumors, stroke, bone fracture, and wounds.

Advisors' Opinion:

• [By Brian Pacampara]

  Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company BioTime (NYSEMKT: BTX  ) has received the dreaded one-star ranking.

• [By John Udovich]

  Stem cell stocks have not exactly been the best performers lately in part because the controversy over their use has died down over the years while major breakthroughs have been few or far between, but the industry along with small cap stem cell stocks Pluristem Therapeutics Inc (NASDAQ: PSTI), BioTime, Inc (NYSEMKT: BTX) and BioRestorative Therapies (OTCBB: BRTX) are still quietly producing their share of news or minor breakthroughs worth taking note of. Just consider the following stem cell news or news from small cap players in the sector:

10 Best Dow Dividend Stocks For 2014: BJ's Restaurants Inc.(BJRI)

BJ?s Restaurants, Inc. owns and operates casual dining restaurants in the Unites States. The company operates restaurants under the BJ?s Restaurant & Brewery, BJ?s Restaurant & Brewhouse, BJ?s Pizza & Grill, or BJ?s Grill names, which offer deep-dish pizzas, handcrafted beers, appetizers, entrees, pastas, sandwiches, specialty salads, desserts, non-alcoholic beverages, wine, other craft beers, and spirits. As of February 27, 2012, it owned and operated 116 restaurants comprising 10 BJ?s Restaurant & Brewery restaurants, 98 BJ?s Restaurant & Brewhouse restaurants, 7 BJ?s Pizza & Grill restaurants, and 1 BJ?s Grill. The company operates restaurants in California, Texas, Arizona, Colorado, Oregon, Nevada, Florida, Ohio, Oklahoma, Kentucky, Indiana, Louisiana, and Washington. BJ?s Restaurants, Inc. was founded in 1991 and is based in Huntington Beach, California.

Advisors' Opinion:

• [By Steve Symington]

  More closely aligned with B-Wild's new efforts, however, are the folks at BJ's Restaurants (NASDAQ: BJRI  ) , who just so happen to integrate their very own enviable list of more than a dozen of BJ's award-winning, handcrafted brews on tap at each of their restaurants. All told, craft brews have served as a centerpiece of BJ's business so far, helping the up-and-coming company to grow to 132 locations in 15 states as of the end of last quarter.

10 Best Dow Dividend Stocks For 2014: 22nd Century Group Inc (XXII)

22nd Century Group, Inc. (22nd Century Group), incorporated on September 12, 2005, is a holding company. The Company�� wholly owned subsidiary, 22nd Century Limited, LLC (22nd Century Ltd), which is a plant biotechnology company. The Company�� products include X-22 Smoking Cessation Aid, Modified Risk Cigarettes, BRAND A Cigarettes and BRAND B Cigarettes. On January 25, 2011, 22nd Century Limited, LLC (22nd Century Ltd) completed a reverse merger transaction (the Merger) with 22nd Century Group, and as a result, 22nd Century Ltd became a wholly owned subsidiary of 22nd Century Group, which continues to operate the business of 22nd Century Ltd. the Company�� drug application for X-22 was cleared by the United States Food and Drug Administration (FDA) in July 2011. The Company�� subsidiary, Goodrich Tobacco Company, LLC (Goodrich Tobacco), had introduced two cigarette brands, RED SUN and MAGIC, into the United States marketed during the year ended December 31, 2011. In December 2013, 22nd Century Group Inc acquired an undisclosed manufacturing facility located in Mocksville, North Carolina. Effective December 11, 2013, 22nd Century Group Inc acquired NASCO Specialty Brands LLC.

X-22 is a tobacco-based botanical medical product for use as a smoking cessation therapy. X-22 is a prescription-only kit consists of very low nicotine (VLN) cigarettes made from its tobacco. The therapy protocol allows the patient to smoke its VLN cigarettes without restriction over the six-week treatment period to facilitate the goal of the patient quitting smoking by the end of the treatment period. In 2011, Biotech Crops were planted in 29 countries on 395 million acres (160 million hectares).

The Company competes with Pfizer Inc., GlaxoSmithKline PLC, Novartis International AG, Reynolds American Inc, Philip Morris USA Inc., Reynolds American Inc., Lorillard Inc., Commonwealth Brands, Inc., Liggett Group LLC, Vector Tobacco Inc., Star Scientific Inc, Philip Morris International Inc., British! American Tobacco, JT International SA, Imperial Tobacco Group PLC and China National Tobacco Corporation.

Advisors' Opinion:

• [By James E. Brumley]

  While it's only been a little over a week since yours truly named 22nd Century Group Inc. (NYSEMKT:XXII) as one of the market's best-looking breakout opportunities, circumstances dictate the message rather than the other way around. That's the indirect way of saying XXII has continued on ahead, behaving as expected, punching through its key ceilings and solidifying the bullishness it was hinting at late last month.

10 Best Dow Dividend Stocks For 2014: Alleghany Corporation(Y)

Alleghany Corporation, through its subsidiaries, engages in the property and casualty, and surety insurance business in the United States. It underwrites specialty insurance coverages in the property, umbrella/excess, general liability, directors and officers liability, professional liability lines of business, and homeowners insurance. The company also writes surety products, such as commercial surety bonds and contract surety bonds. In addition, Alleghany Corporation owns and manages improved and unimproved commercial land, and residential lots in the Sacramento, California. As of December 31, 2010, the company owned approximately 320 acres of property in various land use categories. Further, it engages in the oil and gas exploration and production business. The company was founded in 1929 and is based in New York, New York.

Advisors' Opinion:

• [By Chris Hill]

  Which investors are worth following? In this installment of MarketFoolery, our analysts talk about why they're following Cook and Bynum's Richard Cook and Dowe Bynum, Martin Capital's Frank Martin, Alleghany's (NYSE: Y  ) CEO Weston Hicks, and T. Rowe Price's (NASDAQ: TROW  ) �Preston Athey.�